Ottawa – August 2, 2023 – The Canadian Centre for Ethics in Sport (CCES) announced today that Ludwig Amla, a Canadian Premier League (CPL) soccer athlete affiliated with the Halifax Wanderers Football Club, received a two-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected during an in-competition sample collection session on September 10, 2022, revealed the presence of terbutaline, a prohibited beta-2 agonist.

In response to the CCES’s notification of the adverse analytical finding, the athlete accepted the violation and requested a hearing to determine whether the proposed sanction period should be eliminated or reduced. Terbutaline is classified as a specified substance on the Prohibited List and based on an assessment of the athlete’s degree of fault, the CCES proposed a two-year period of ineligibility. On July 14*, 2023, Arbitrator Richard Pound, C.C., O.Q., K.C., F.C.A, confirmed the violation and imposed a two-year sanction, which terminates on February 7, 2025, because the athlete was deemed to have accepted a provisional suspension.**

During the sanction period, the athlete is ineligible to participate in any capacity with any sport signatory to the CADP, including training with teammates.

The full decision can be found at www.crdsc-sdrcc.ca.

*Date corrected from original publication. 
**Edited August 17, 2023.

About the CCES

The CCES works collaboratively to ensure Canadians have a positive sport experience. Through its programs, the CCES manages unethical issues in sport, protects the integrity of Canadian sport, and promotes True Sport to activate values-based sport on and off the field of play. The CCES is an independent, national, not-for profit organization that is responsible for the administration of the CADP. Under the CADP rules, the CCES makes public every anti-doping rule violation. For more information, visit cces.ca, follow us on Twitter, Facebook, or Instagram.
 

For further information, please contact:

+1 613-521-3340 x3233
[email protected]

See Also...